Skip to main content
OpenTrials

Clinical trial condition

Bacterial Infections

Explore clinical trials studying Bacterial Infections. Study availability and eligibility vary by location and protocol.

4,522 public trials 496 recruiting studies
Refine in advanced search Browse all conditions

Bacterial Infections trial results

Completed

Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children

NCT01900899

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Espoo Vaccine Research Clinic Espoo, Finland
  • Tampereen yliopisto/ Etela-Helsingin rokotetutkimusklinikka Helsinki, Finland
  • Helsinki East Vaccine Research Clinic Helsinki, Finland
  • Tampereen Yliopisto/ Jarvenpaan rokotetutkimusklinikka Jarvenpaa, Finland
View Trial Details
Completed

Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.

NCT01682876

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site Lake Mary, Florida, United States
  • GSK Investigational Site Marietta, Georgia, United States
View all 19 locations
View Trial Details
Completed

Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age

NCT03642847

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations
  • Collaborative Neuroscience Network, LLC. Garden Grove, California, United States
  • Collaborative Neuroscience Network, LLC. Long Beach, California, United States
  • East-West Medical Research Institute Honolulu, Hawaii, United States
  • Clinilabs Drug Development Corporation Eatontown, New Jersey, United States
View Trial Details
Completed

Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults

NCT00385255

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +13 more
Locations
  • GSK Investigational Site Huntsville, Alabama, United States
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
View Trial Details
Completed

Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.

NCT00370396

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +7 more
Locations
  • GSK Investigational Site Espoo, Finland
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Jarvenpaa, Finland
View all 35 locations
View Trial Details
Completed

The Long-term Antibody Persistence of MenACWY-TT Vaccine (PF-06866681) Versus Meningitec(Registered) or Mencevax(Registered) ACWY in Healthy Adolescents and Adults and a Booster Dose of MenACWY-TT Administered 10 Years Post Primary Vaccination

NCT01962207

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Espoo Vaccine Research Clinic Espoo, Finland
  • South Helsinki Vaccine Research Clinic Helsinki, Finland
  • Helsinki East Vaccine Research Clinic Helsinki, Finland
  • Jarvenpaa Vaccine Research Clinic Jarvenpaa, Finland
View Trial Details
Completed

Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI)

NCT01716533

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Clostridium Infections, +3 more
Locations
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Houston, Texas, United States
  • GSK Investigational Site Hamilton, Ontario, Canada
View Trial Details
Completed

Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV)

NCT01201057

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Bacterial Vaginosis, +9 more
Locations
  • Precision Trials Phoenix, Arizona, United States
  • Downtown Women's Health Care Denver, Colorado, United States
  • Clinical Research Center of Nevada Las Vegas, Nevada, United States
  • Bexar Clinical Trials, LLC Irving, Texas, United States
View Trial Details

Related conditions